Orgenesis Inc. Profile Avatar - Palmy Investing

Orgenesis Inc.

Orgenesis Inc., a biotech company, focusing on cell and gene therapies worldwide. The company develops a Point of Care (POCare) platform that includes a pipeline of licensed POCare therapeutics that are processed and produced in closed automated POCare t…

Biotechnology
US, Germantown [HQ]

Document Reader

Click To Read:

DEF 14-A Proxies

Not a single DEF 14-A proxy doc.

10-K Filings

Not a single 10-K doc.

10-Q Filings

Not a single 10-Q doc.

LDA 1/2 Filings [Lobbying]

Not a single LDA doc.

End of ORGS's Analysis
CIK: 1460602 CUSIP: 68619K204 ISIN: US68619K2042 LEI: - UEI: -
Secondary Listings
ORGS has no secondary listings inside our databases.